Journal of Cellular and Molecular Medicine · 2019 · 73 citations · 35 references
MedicineBiochemistryPharmacologyBiochemical PharmacologyMetabolismMolecular PharmacologyAdipose TissueFatty Acid MetabolismInsulin ResistanceLigand BindingLipid MetabolismTriglyceride MetabolismGlucose Metabolism DisordersGlucose Metabolism EffectsHepatic Insulin ResistancePeroxisome Proliferator-activated Receptor Alpha (Ppar-alpha) SignalingTraditional Chinese Medicine
Obesity and its associated metabolic disorders such as diabetes, hepatic steatosis and chronic heart diseases are affecting billions of individuals. However there is no satisfactory drug to treat such diseases. In this study, we found that alisol A, a major active triterpene isolated from the Chinese traditional medicine Rhizoma Alismatis, could significantly attenuate high-fat-diet-induced obesity. Our biochemical detection demonstrated that alisol A remarkably decreased lipid levels, alleviated glucose metabolism disorders and insulin resistance in high-fat-diet-induced obese mice. We also found that alisol A reduced hepatic steatosis and improved liver function in the obese mice model.In addition, protein expression investigation revealed that alisol A had an active effect on AMPK/ACC/SREBP-1c pathway. As suggested by the molecular docking study, such bioactivity of alisol A may result from its selective binding to the catalytic region of AMPK.Therefore, we believe that Alisol A could serve as a promising agent for treatment of obesity and its related metabolic diseases.
35
Marie Ng, Tom Fleming, Margaret S. Robinson et al. · The Lancet · 2014 · 12.1K citations · Full text
Kerry L. Donnelly, Coleman I. Smith, Sarah Jane Schwarzenberg et al. · Journal of Clinical Investigation · 2005 · 3.5K citations · Full text
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
Sung Jun Park, Faiyaz Ahmad, Andrew Philp et al. · Cell · 2012 · 1.3K citations · Full text